Wyeth Finally Cleared For Pristiq Lift-Off, But With Lower Dose

Approval of Wyeth's Pristiq (desvenlafaxine) comes at the lower dose that was submitted late in the review process and with a request for a postmarketing study to determine if even lower doses would be effective

More from Archive

More from Pink Sheet